文献速递衰弱、肌少症与跌倒老年综合评估

肌少性肥胖与老年人衰弱风险的系统综述与荟萃分析

Association between sarcopenic obesity and risk of frailty in older adults: a systematic review and meta-analysis.
PubMed 文献 · Age Ageing · 2025-01-01

结果显示,与健壮老年人相比,肌少性肥胖者衰弱风险显著升高(OR 3.76,95%CI 2.62–5.39,P<.0001);在肌少症老年人中,肥胖与衰弱风险无显著关联(OR 1.23,95%CI 0.99–1.53,P=.501)。结论认为肌少性肥胖与高衰弱风险相关,肌少症与肥胖可能对衰弱有协同效应。

要点

  • 肌少性肥胖老年人衰弱风险约为健壮者的3.76倍(95%CI 2.62–5.39)。
  • 在肌少症老年人中,肥胖与衰弱风险无显著关联(OR 1.23,95%CI 0.99–1.53)。
  • 肌少症与肥胖可能对老年人衰弱存在协同效应。

核心结论

  • 肌少性肥胖与老年人高衰弱风险相关。
  • 肌少症与肥胖可能对老年人衰弱产生协同效应。

研究设计与样本

  • 系统综述与荟萃分析,检索六个数据库自建库至2024年9月29日。
  • 由两名评价者独立提取数据,并使用改编的纽卡斯尔-渥太华量表评估偏倚风险。
  • 对照组包括健壮、肥胖和肌少症个体。

主要发现

  • 与健壮老年人相比,肌少性肥胖老年人衰弱风险显著升高(OR 3.76;95%CI 2.62至5.39;I2=79.3%;P<.0001)。
  • 在肌少症老年人中,肥胖与衰弱风险无显著关联(OR 1.23;95%CI 0.99至1.53;I2=0.0%;P=.501)。

临床怎么用

  • 对老年患者应关注肌少性肥胖表型,并将其纳入衰弱风险评估。
  • 在肌少症老年人中,不能仅凭肥胖判断衰弱风险高低,需综合评估。

局限性

  • 纳入研究均为观察性研究,存在偏倚风险。
  • 肌少性肥胖与衰弱关联的异质性较高(I2=79.3%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Age-related changes in body composition such as muscle loss can lead to sarcopenia, which is closely associated with frailty. However, the effect of body fat accumulation on frailty in old age remains unclear. In particular, the association between the combination of these two conditions, known as sarcopenic obesity, and frailty in older adults is unclear. OBJECTIVE: To synthesise the association between sarcopenic obesity and the risk of frailty and to investigate the role of obesity in the risk of frailty in old age. METHODS: Six databases were searched from inception to 29 September 2024. Two reviewers independently extracted the data and assessed the risk of bias for the included observational studies using the adapted Newcastle-Ottawa scale. The control groups consisted of robust, obese and sarcopenic individuals. Meta-analyses were performed to examine the risk of frailty due to sarcopenic obesity and the role of obesity in frailty amongst sarcopenic older adults. RESULTS: Sixteen eligible studies were included in meta-analyses from 1098 records. Compared to robust individuals, older adults with sarcopenic obesity were more vulnerable to frailty [odds ratio (OR), 3.76; 95% confidence interval (CI), 2.62 to 5.39; I2 = 79.3%; P < .0001]. Obesity was not associated with the risk of frailty (OR, 1.23; 95% CI, 0.99 to 1.53; I2 = 0.0%; P = .501) in sarcopenic older adults. CONCLUSIONS: Sarcopenic obesity is associated with a high risk of frailty. Sarcopenia and obesity may have synergistic effects on frailty in older adults.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Gengxin Y, Xuehan M, Xinyu W, et al. Association between sarcopenic obesity and risk of frailty in older adults: a systematic review and meta-analysis. Age Ageing. 2025. PMID: 39775783. doi:10.1093/ageing/afae286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。